Archive

  • LGIM axes sale of Manchester skyscraper to preserve alternatives exposure

    27 February 2024

    Affiliate had announced sale of North Tower at the end of last year

  • Aviva Investors acquires two UK resi developments

    27 February 2024

    Bought alongside partner Packaged Living from developers Dandara

  • Axa IM appoints new head of global rates

    27 February 2024

    Jérôme Broustra takes on role after two decades at the company

  • German lifers' optimism for fund-linked sales outshines all other policy types

    27 February 2024

    GDV surveyed lifers, and other underwriters, in Q4 2023

  • T&D Financial Life helps customers see the future of their investments - using AI

    27 February 2024

    Japanese lifer is offering an AI engine to foretell direction of fund unit prices

  • Insurers lead South Korea financial firms in KRW 32trn foreign property allocations

    27 February 2024

    Financial Supervisory Service has published data for September

  • Comment: Share prices suggest insurers' shareholders might not care much about the 'G' in ESG

    26 February 2024

    Shareholders of Japan's insurers pocketed 150% since Q1 2020 while the Topix made 98% - so do the sector's governance issues matter?

  • Insurance Risk Data hosts free webinar on GA allocations by market risk sub-modules

    26 February 2024

    Webinar reveals €1.6trn GA allocations by elements of market risk, then by asset class

  • NN Group invests €350m in strategy that will look beyond traditional renewables investments

    26 February 2024

    Dutch insurer partners with Macquarie Asset Management to make debt deals

  • Life sciences real estate flourishing but in need of careful tending

    26 February 2024

    Pandemic-induced awareness of biotech R&D combined with long-term demographic trends have put life sciences real estate in the spotlight, but investment here is both delicate